Global Market Report on Metabolomics: Technologies Industry [2015]

1. Report on Metabolomics Technologies Industry

2. Summary The global metabolomic market totaled $5.9 billion in 2014 and should total $6.8 billion in 2015 and $12.5 billion by 2020, registering a compound annual growth rate (CAGR) of 13.0%. This report provides: -An overview of the commercial potential of the metabolomics research field, the systematic study of the unique chemical fingerprints that cellular processes leaves behind -Analyses of global market trends, with data from 2014, estimates for 2015 and projections of compound annual growth rates (CAGRs) through 2020

3. STUDY GOALS AND OBJECTIVES The report goal in conducting this study was to update the status of the metabolomic market and assess its growth potential over the five-year period from 2015 to 2020. Particularly focus was placed on understanding the current market adoption and analyzing drivers for increasing this in terms of both scope (i.e., more applications) and maturity in terms of user adoption, collaboration with regulators and the emergence of standards. In addition, the report was interested in understanding the impact of these methods on different research sectors, specifically cancer, toxicology and safety testing; as well as the clinical application of biomarkers in cancer, cardiology, and liver and metabolic disease.

4. REASONS FOR DOING THE STUDY Metabolomics is a fairly new field relative to genomics and proteomics, which are more mature, but it promises much needed breakthroughs by virtue of being more descriptive of the actual phenotype or working conditions of the human body. Whereas genomics describes the body’s code and proteomics the application of that code into the proteins that do the work, metabolomics describes and measures the resultant interaction of an individual’s unique body with those proteins and with the environment. This report details the recent key technical advances in metabolomic methods, analytical equipment, assay kits, bioinformatics solutions and clinical biomarker applications.

5. SCOPE OF REPORT The scope of the report encompasses the major metabolomic technology types that have been used, as well as the major applications being developed by industry, academic researchers and their commercialization offices, and government agencies. Technology developments, including the latest trends, are discussed. Other influential factors such as screening strategies for pharmaceuticals have also been included. INTENDED AUDIENCE This report is designed to satisfy the information needs of a wide variety of individuals involved in the cancer, cardiovascular, metabolic and liver disease, including company senior management executives seeking to base their strategic decisions on the latest insights into market forces and application trends. It is also aimed at managers and executives in product research and development (R&D), particularly those responsible for bringing new products to market.

6. INFORMATION SOURCES Both primary and secondary research methodologies were used in preparing this study. Primary research included interviews with leading individuals in relevant companies and associations. Primary sources of published data included research studies, company annual reports and government publications. Secondary sources consisted of literature searches, industry journals and other commercial publications. Data for market estimates and forecasts are pooled from a range of sources critically assessed by BCC Research.

7. Table of Contents 1: INTRODUCTION 2: SUMMARY 3: OVERVIEW OF METABOLOMICS 4: METABOLOMIC ANALYTICAL PROCESSES AND INSTRUMENT 5: ASSAY COMPONENTS AND KITS FOR METABOLOMICS 6: BIOINFORMATICS IN METABOLOMICS 7: CLINICAL BIOMARKERS 8: COMPANY PROFILES

8. To view the full Executive Summary and Table of Contents, please visit: Report on Metabolomics Technologies Industry Contact Us:- Phone : +91-22-27810772/73 Email id : info@bharatbook.com Website : www.bharatbook.com Our Blog : https://www.bharatbook.com/blog/